- Home
- CENX vs CNTA Comparison
CENX vs CNTA Comparison
Compare CENX & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CENX | CNTA |
|---|---|---|
| Founded | 1995 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Aluminum | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CENX | CNTA |
|---|---|---|
| Price | $45.12 | $24.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $41.00 | $38.50 |
| AVG Volume (30 Days) | ★ 2.1M | 1.7M |
| Earning Date | 02-19-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.83 | N/A |
| Revenue | ★ $2,525,100,000.00 | $15,000,000.00 |
| Revenue This Year | $16.70 | N/A |
| Revenue Next Year | $6.25 | N/A |
| P/E Ratio | $58.67 | ★ N/A |
| Revenue Growth | 20.15 | ★ 118.88 |
| 52 Week Low | $13.05 | $9.60 |
| 52 Week High | $52.00 | $30.58 |
Technical Indicators
Market Signals| Indicator | CENX | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 52.98 | 51.79 |
| Support Level | $44.62 | $21.50 |
| Resistance Level | $52.00 | $26.63 |
| Average True Range (ATR) | 2.70 | 1.20 |
| MACD | -0.56 | 0.36 |
| Stochastic Oscillator | 8.17 | 61.31 |
Price Performance
Historical ComparisonAbout CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.